Equifax Inc. (LON:0II3)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	22,429	25,222	23,922	19,751	26,381	17,181
Market Cap Growth	-0.85%	5.44%	21.11%	-25.13%	53.54%	34.12%
Enterprise Value	26,084	29,328	28,459	24,446	28,936	19,290
Last Close Price	181.58	204.89	192.57	158.90	210.57	137.25
PE Ratio	48.04	52.27	55.88	34.18	48.00	45.10
PS Ratio	5.26	5.56	5.79	4.65	7.26	5.68
PB Ratio	5.87	6.42	6.50	5.99	9.92	7.31
P/FCF Ratio	-	38.84	59.11	179.47	41.26	44.69
P/OCF Ratio	-	23.84	27.28	31.43	26.76	24.79
EV/Sales Ratio	5.92	6.46	6.89	5.75	7.96	6.38
EV/EBITDA Ratio	18.48	20.89	22.85	17.76	24.07	24.12
EV/EBIT Ratio	30.94	34.10	37.51	27.02	34.42	38.02
EV/FCF Ratio	38.97	45.16	70.32	222.14	45.25	50.18
Debt / Equity Ratio	0.94	1.05	1.22	1.46	1.47	1.36
Debt / EBITDA Ratio	2.62	2.86	3.60	3.49	3.25	4.01
Debt / FCF Ratio	5.34	6.36	11.08	43.65	6.12	8.34
Asset Turnover	0.49	0.47	0.44	0.45	0.48	0.47
Quick Ratio	0.63	0.64	0.58	0.60	0.42	0.94
Current Ratio	0.77	0.75	0.67	0.68	0.49	1.00
Return on Equity (ROE)	12.76%	12.64%	12.74%	18.49%	21.98%	18.04%
Return on Assets (ROA)	5.80%	5.60%	5.07%	6.03%	6.89%	4.94%
Return on Capital (ROIC)	6.82%	6.57%	5.99%	7.31%	8.63%	6.37%
Return on Capital Employed (ROCE)	11.20%	10.80%	9.40%	11.40%	13.00%	9.70%
Earnings Yield	2.08%	1.91%	1.79%	2.93%	2.08%	2.22%
FCF Yield	2.98%	2.57%	1.69%	0.56%	2.42%	2.24%
Dividend Yield	0.54%	0.61%	0.64%	0.81%	0.55%	0.83%
Payout Ratio	32.41%	31.98%	35.17%	27.45%	25.53%	36.44%
Buyback Yield / Dilution	-0.56%	-0.81%	-0.49%	0.24%	-0.65%	-1.57%
Total Shareholder Return	-0.03%	-0.20%	0.15%	1.06%	-0.10%	-0.74%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.